It is a chemicals and resources private limited company based in Mumbai, Maharashtra, India, established in 2010.
2010 | Mumbai, Maharashtra, India | Converted to LLPKyoto Bio Pharma Private Limited, a converted to llp private limited company, was established on 20 September 2010 in Mumbai, Maharashtra, India. Engaging in specialized chemicals within the manufacturing sector, it holds CIN: U24233MH2010PTC207893. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Formerly known as Kyoto Fuels & Chemicals Private Limited. Its leadership includes Rajnikant Nalawade Annasaheb (Director), Sunita Rajesh Katkar (Director). Past directors included Rajnikant Nalawade Annasaheb, Manoj Gulshanlal Bindra. Its latest AGM occurred on 01 September 2016, with the balance sheet filed on 31 March 2016. It is based at B-25, Gr Flr, Station Plaza Commercial Premises Station Plaza, Station Road Bhandup (We, St), Mumbai, Maharashtra, 400078.
U24233MH2010PTC207893
207893
20 September 2010
₹0.10 M
₹0.10 M
Roc Mumbai
Unlisted
Converted to LLP
Explore comprehensive insights into Kyoto Bio Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajnikant Nalawade Annasaheb | Director | 10 Dec 2013 | Current |
| Sunita Rajesh Katkar | Director | 20 Sep 2010 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2014 | Past |
| Pramod Abcsdd | Director | 10 Dec 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Kyoto Bio Pharma Private Limited, for the financial year ended 2016, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 62.91% increase in profit. The company's net worth dipped by a decrease of 5.8%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2016, Kyoto Bio Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Kyoto Bio Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Kyoto Bio Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kyoto Bio Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Kyoto Bio Pharma Private Limited last Annual general meeting of members was held on 01 Sep 2016 as per latest MCA records. was documented.
Kyoto Bio Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2016 with Roc Mumbai. was recorded as a recent event.
Rajnikant Nalawade Annasaheb was appointed as a Director was appointed as a Director on 10 Dec 2013 & has been associated with this company since 11 years 11 months . was recorded as a recent event.
Sunita Rajesh Katkar was appointed as a Director was appointed as a Director on 20 Sep 2010 & has been associated with this company since 15 years 2 months . was recorded as a recent event.
Kyoto Bio Pharma Private Limited was registered on 20 Sep 2010 with Roc Mumbai & aged 15 years 2 months as per MCA records. was recorded as a recent event.
The CIN of Kyoto Bio Pharma Private Limited is U24233MH2010PTC207893.
Kyoto Bio Pharma Private Limited is headquartered at B-25, Gr Flr, Station Plaza Commercial Premises Station Plaza, Station Road Bhandup (We, St), Mumbai, Maharashtra, 400078.
Kyoto Bio Pharma Private Limited was incorporated on 20 September 2010.
The current directors of Kyoto Bio Pharma Private Limited are
The primary industry of Kyoto Bio Pharma Private Limited is Manufacturing.
Kyoto Bio Pharma Private Limited is unlisted.
The authorized capital of Kyoto Bio Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX